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Background—Heritability may play a role in nonfamilial atrial fibrillation (AF). We hypothesized that a monozygotic
(MZ) twin whose co-twin was diagnosed with AF would have an increased risk of the disease compared with a dizygotic
(DZ) twin in the same situation.
Methods and Results—A sample of 1137 same-sex twin pairs (356 MZ and 781 DZ pairs) in which one or both members
were diagnosed with AF were identified in The Danish Twin Registry. Concordance rates were twice as high for MZ
pairs than for DZ pairs regardless of sex (22.0% versus 11.6%, P0.0001). In a Cox regression of event-free survival
times, we compared the time span between occurrences of disease in MZ and DZ twins. The unaffected twin was
included when his or her twin-sibling (the index twin) was diagnosed with AF. After adjustment for age at entry, MZ
twins had a significantly shorter event-free survival time (hazard ratio, 2.0; 95% CI, 1.3 to 3.0), thereby indicating a
genetic component. Using biometric models, we estimated the heritability of AF to be 62% (55% to 68%), due to
additive genetics. There were no significant differences across sexes.
Conclusions—All the analyses of twin similarities in the present study indicate that genetic factors play a substantial role
in the risk of AF for both sexes. The recurrence risk for co-twins (12% to 22%) is clinically relevant and suggests that
co-twins of AF-affected twins belong to a high-risk group for AF. (Circ Arrhythmia Electrophysiol. 2009;2:378-383.)
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Atrial fibrillation (AF) is a common type of arrhythmia,currently affecting more than 5% of the Western popu-
lation over 65 years of age.1 AF is associated with risk of
thromboembolic complications, heart failure, and death.2 It is
more common in men than women and in those with heart
failure, valvular heart disease, hypertension, diabetes, and
with increasing age.3,4 In approximately 12% (to 30%) of AF
patients, no concomitant heart disease is present, a condition
known as “lone AF.”5,6 Although AF is a common disease
and constitutes a major problem in public health,7 current
treatment methods for AF are far from satisfactory. Various
treatment strategies are currently used, but the recurrence rate
is high, and many patients eventually have development of
permanent AF refractory to any attempt to obtain sinus
rhythm (SR), including electric cardioversion. This lack of
true success in treatment of AF is partly explained by the
scarce knowledge of the pathogenesis of AF.
Clinical Perspective on p 383
It is not known why the majority of individuals with
hypertension or valvular or structural heart disease remain in
SR even in an advanced age, whereas others have AF in the
absence of these or any other known risk factors. These facts
make it reasonable to consider AF a multifactorial disease in
which genetic factors may play an important role in defining
the risk for the development of the disease.
In 1947, Wolff8 described 3 brothers who all were diag-
nosed with AF at a young age, and since then there has been
a debate about the heritability of this arrhythmia. From
kindreds with familial AF, we know that certain mutations
can cause the disease, but until now only private mutations
not found outside the actual family have been described.9–11
On the other hand, common polymorphisms have been shown
to associate with the risk of AF in patients with nonfamilial
AF and in the general population at large.12–16 These findings
indicate that AF to some degree is a polygenetic disease. An
attempt to estimate the heritability of AF in the general popula-
tion has been done with data from the Framingham Heart Study,
showing that parental AF is a risk factor for AF in offspring.12
Likewise, a study of the general population in Iceland demon-
strated that Icelandic patients with AF are more closely related
to each other than the rest of the population, suggesting a
significant degree of heritability in nonfamilial AF.17
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No relatives are genetically closer to each other than
monozygotic twins. When twin populations are sampled and
followed, it is possible to collect epidemiological data con-
cerning more common diseases, their distribution, incidence,
and prevalence, and their relation to sex, age, zygosity, and so
forth. The classic comparisons between monozygotic (MZ)
twins (with completely identical genes) and dizygotic (DZ)
twins (with no more genes in common than ordinary sib
pairs), can provide estimates of heritability, that is, the extent
to which the variation in a given population with respect to a
certain trait is gene dependent.18 In the present study, we
investigated the incidence of AF among Danish twins whose
twin-sibling (ie, index twin) already had the disease, and,
from calculations of concordance rates and hazard ratios, we
aimed at estimating the co-twin risk of being diagnosed with
AF during follow-up and the heritability of nonfamilial AF.
Methods
The Danish Twin Registry is a nationwide and population-based
registry, established in 1954. The registry contains information about
twins born between 1870 and 2004 and identified through church
records or through the Central Office of Civil Registration. The
registry currently holds data of more than 75 000 Danish twin pairs.
All twins in the registry are ascertained independently of any disease.
Zygosity is self-reported and established through a questionnaire
with questions on the degree of similarity between twins in a
pair.19,20 Validity of this kind of classification has been evaluated
through blood samples and misclassification found to be less than
5% of cases.21
Information on diagnosis (World Health Organization; Interna-
tional Classification of Diseases, 8th edition: code 427.4; 10th
edition: code I48.9) was collected from The Danish National Patient
Registry. This registry contains information about all patient contacts
with all Danish Hospitals since 1977, including the specific hospital
and department, admission and discharge dates, and diagnoses
(www.sst.dk).
Through merging information from the 2 registries, all twin pairs
in which at least 1 of the twins was diagnosed with AF were
identified. For all twins identified, the following information was
sampled: zygosity, sex, time of birth, vital status, time of death or
emigration, and time of first diagnosis of AF. From the initial data
set, twins born earlier than January 1, 1912, were excluded to avoid
misclassification due to diagnosis not registered in The Danish
National Patient Registry. Twins with unknown zygosity and twin
pairs with information only on 1 twin were also excluded from the
dataset. Opposite sex twin pairs were excluded because data on
opposite twin pairs are only available for a fraction of the cohorts
under study.20 Furthermore, before entering the Cox proportional
hazards model, twin pairs in which the co-twin was lost to follow-up
before diagnosis of the index twin were excluded. Finally, 1 pair of
twins was excluded due to doubt of diagnosis as the index twin
apparently was diagnosed at the age of 7.
Statistical Analysis
Analysis of Proband-Wise Concordance Rates
The proband-wise concordance rate is the probability that a twin gets
the disease given that his or her twin partner already has the disease.
Concordant twin-pairs are defined as pairs in which both twins have
been diagnosed with AF and discordant twin-pairs as pairs in which
only 1 twin has the diagnosis. The proband-wise concordance rate is
preferred to other types of concordance rates because it does not vary
with the ascertainment probability and is found to equal on average
the population case-wise rate.22
Because MZ twins are completely identical for all genetic factors
and DZ twins share on average 50% of their genes, higher concor-
dance rates among MZ twins are interpreted to be caused by genetic
factors. Differences between concordance rates for MZ and DZ twins
are tested with the 2 test with 1 degree of freedom. The concordance
rates were calculated manually, using the formula for proband-wise
concordance rates.
Cox Proportional Hazards Model
The genetic effect was explored using survival analysis in the Cox
proportional hazards model. The diagnosis-free time after diagnosis
of the index twin was compared between MZ and DZ twins. The
index twin is defined as the twin first diagnosed with AF within a
twin pair. The co-twin is defined as the twin who is the twin-sibling
of the index twin.
A shorter time span between occurrences of disease in MZ twins
would be indicative of a genetic effect. Thus, for each twin pair, we
calculated the time span from diagnosis of the index twin to
diagnosis of the co-twin. For some pairs this time was right-censored
because of end of follow-up or death. In a Cox model, the relation
between time from diagnoses and zygosity, sex, and age was
assessed. In further analysis, we included an interaction term
between sex and zygosity to assess whether the genetic effect is
dependent on sex. To investigate the genetic effect in younger twins,
we analyzed the twins divided into 2 strata defined as 65 years and
65 years. Results are given as hazard ratios with 95% confidence
limits. Cumulative incidence curve was constructed from Kaplan-
Meier coordinates and differences between strata (zygosity) evalu-
ated by log-rank test. We used SAS version 9.1 and the procedure
“proc phreg,” calculating the Cox proportional hazards model.
Biometric Models
Biometric models were used to estimate the heritability. The relative
importance of genetic factors is assessed by the liability approach.
Liability is based on threshold models, reflecting prevalence on a
latent distribution of liability. Individuals above this threshold are
assumed to have the trait of interest, whereas individuals under the
threshold are assumed not to have the trait.23
The correlation between relatives—in the present study, MZ and
DZ twins—is used to partition the correlation into components
attributable to shared genes and environments, to estimate heritabil-
ity. The correlation coefficients rMZ and rDZ calculated for MZ and
DZ twins, respectively, provides information of genetic as well as
environmental influences, and, assuming equal environments, differ-
ences in the 2 correlation coefficients will represent the influence of
genetic factors. The following relations are the standard assumptions
about the quantitative genetics:
rMZa
2d2c2, rDZ0.5 a20.25 d2c2,
and 1a2d2c2e2
where a2 corresponds to the proportion of the total variance associ-
ated with additive genetic effects (A), d2 with dominant genetic
effects (D), c2 with shared environmental effects (C), and e2 with
nonshared environmental effects (E). All components are assumed to
be independent. Different genetic models can be tested combining
these elements, but no more than 3 components can be simulta-
neously represented in a model for MZ and DZ twins reared together.
An ADE model refers to decomposition of frailty ZADE, an
AE model refers to ZAE, and so on. Dominant and shared
environmental factors cannot be represented simultaneously because
of confounding of the two in a study of twins reared together. The
model assumes no epistasis, no gene-environment interaction, and no
assortative mating. Selection of the best-fitted model is based on
Akaike information criterion (AIC22 df). We used Mx soft-
ware24 for the estimation procedures, and all models were fitted to
contingency tables separately for men and women.
Subanalysis of Early Onset AF
To study the effect of zygosity and sex in the younger age groups, we
used a cutoff age of 65 years at the time of diagnosis of proband.
This value was chosen as a compromise to define a population as
young as possible without loosing the possibility to perform the
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analysis at all due to too low number of events. The estimates were
calculated as odds ratios with 95% confidence limits from a 22
table using the 2 and Fisher exact test.
Results
A total of 1137 twin pairs were identified, 356 MZ and 781
DZ pairs. Of these 1137 pairs, 92 were concordant and 1045
were discordant pairs. Mean age of the concordant pairs at
inclusion (time of first diagnosis) was 68.2 years and for the
discordant pairs, 67.7 years (Table 1).
Concordance Rates
Proband-wise concordance rates are shown in Table 2.
Analyzing all 1137 twins in 1 group regardless of sex showed
concordance rate for MZ twins approximately twice the rate
for DZ twins: 22.0% versus 11.6% (P0.0001). Stratifying
for sex did not change these figures significantly: 23.3%
versus 11.4% (P0.001) for women and 21.1% versus 11.7%
(P0.001) for men.
Cox Proportional Hazards Model
From the original total number of 1137 twin pairs, we
identified 806 pairs, 255 MZ and 551 DZ pairs, in which the
co-twins were alive after the diagnosis of the index twin and
thus fitted into a Cox proportional hazard model. The risk of
AF was significantly associated with monozygosity (hazard
ratio [HR], 2.0; 95% CI, 1.3 to 3.0; P0.0009). The disease
rate is twice as high in MZ twins compared with DZ twins
(Figure), and this difference is clearly statistically significant,
indicating that AF has a genetic component. As expected,
entry age had a strong effect on AF risk (HR, 1.5; 95% CI, 1.2
to 1.9) for each 10-year increase P0.0001). Disease rate was
30% higher in men but not statistically different from the
female rate (HR, 1.3; 95% CI, 0.84 to 2.0; P0.24). When
analyzing 2 age groups separately, we find a stronger genetic
effect of zygosity in twins65 years than in twins 65 years
(HR, 2.9; P0.0036 versus HR, 1,65; P0.0514); the differ-
ence is not statistically significant (P0.21). This effect was
expected, as we see a tendency for the time to diagnosis of the
co-twin to decrease as a function of the age of the index twin
at time of his or her diagnosis. The effects of age as an
independent risk factor play a role.
In the analysis allowing for a sex-dependent effect of
zygosity, this appeared to be stronger for women (HR, 2.1;
95% CI, 1.2 to 4.0; P0.017) than for men (HR, 1.9; 95% CI,
1.1 to 3.3; P0.021), but the difference between the sexes
was not statistically significant (P0.78). This difference
was even more pronounced though still not statistically
significant when analyzed for the younger age groups. Ana-
lyzing only patients younger than 65 years at time of
diagnosis of proband showed the odds ratio for women at 5.2
(95% CI, 1.2 to 23.1; P0.034) and for men, 2.7 (95% CI, 1.1
to 6.7; P0.020) (Table 3).
Biometric Models
Contingency tables along with prevalence for AF divided into
sex and zygosity groups are shown in Table 4. Tetrachoric
Table 1. Baseline Characteristics of Participants by Zygosity
and Diagnostic Status at Inclusion
All Female Male
Discordant pairs
No. of pairs 1045 453 592
Age, y 68.2 (13.2) 71.7 (11.8) 65.5 (13.5)
Zygosity (MZ) 312 (30%)* 125 (28%)† 187 (32%)‡
Concordant pairs
No. of individuals 92 40 52
Age, y 67.7 (11.1) 71.8 (9.3) 64.5 (11.5)
Zygosity (MZ) 44 (48%)* 19 (48%)† 25 (48%)‡
Continuous variables are mean (SD).
*P0.001, †P0.05, ‡P0.01, by Student t test for continuous values or
2 for categorical values comparing discordant and concordant pairs.
Table 2. Number of Concordant and Discordant Twin Pairs and Proband-Wise Concordance
Rates for AF by Sex and Zygosity
Both Sexes Women Men
Zygosity MZ DZ MZ DZ MZ DZ
Total No. of AF twin pairs 356 781 144 349 212 432
Concordant pairs 44 48 19 21 25 27
Discordant pairs 312 733 125 328 187 405
Proband-wise concordance rate, % 22.0* 11.6* 23.3† 11.4† 21.1‡ 11.7‡
Concordant pairs are pairs in which both twins have the disease; discordant pairs are pairs in which only 1 twin
has the disease. Concordance rate is the probability that an affected twin has a co-twin who is also affected.
Differences between proband-wise concordance rates (in percentages) in MZ and DZ twins are statistically significant.
*P0.0001, †P0.001, ‡P0.001.
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Figure. Plot of cumulative incidence of AF as a function of
zygosity for both sexes analyzed together.
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correlations for men and women are given in Table 5 together
with probability values for test of homogeneity of thresholds
across zygosity groups. Women show significantly different
thresholds (P0.01) caused by differing prevalence in the
zygosity groups, whereas there is no difference for men
(P0.08). Assuming the same thresholds across zygosity
groups, within the sexes there is a significant difference in
thresholds (and thereby prevalence) between men and women
(P0.001). Model-fit statistics for the biometric models are
shown in Table 6; the AE model provided the best-fitting model
(lowest AIC) for both men and women. The heritability of AF
was estimated to be 67% (95% CI, 57% to 76%) among women
and 59% (95% CI, 49% to 67%) among men because of additive
genetic effects (Table 7). The difference in heritability of men
and women was not statistically significant, and the common
estimate is 62% (95% CI, 55% to 68%).
Discussion
In the present study of Danish twins with AF, we demonstrate
that once a twin is diagnosed with AF, the probability of his
or her co-twin getting the disease is associated with zygosity.
Two studies have previously addressed the heritability of
nonfamilial AF or AF in the general population, concluding
that risk of AF to some extent is a heritable condition,12,17 but
these studies have not been able to disentangle the effect of
common familial environment and genetic factors. Because
MZ twins have completely identical genes, no relatives are
genetically closer to each other than they, and we assume that
any variation in concordance rates of AF between MZ and DZ
twins will be gene dependent.
Comparisons of concordance rates as well as analysis of
twin similarities indicate that genetic effects play a significant
role for the risk of AF for both sexes. Concordance rates for
MZ twins are more than twice the rates for DZ twins when
both sexes are analyzed in 1 group, 22.0% versus 11.6%, and
this difference is highly significant (P0.0001) Analyzing
both sexes separately did not change these figures (Table 2).
The analysis of twin similarities further supports this by
estimating the heritance of AF to be 62% due to additive
genetic factors (ie, the effect of the genetic factors are acting
additively and not primarily as gene-gene interaction, which
would have been reflected in a more than factor 2 difference
in the correlation for MZ and DZ twins) (Table 7).
Cox proportional hazard regression models with age and
sex as covariates showed a hazard ratio of 2.0 for develop-
ment of AF for an MZ twin once his or her twin-sibling had
developed the disease. Analyzing twins younger than and
older than 65 years separately showed that this effect is even
stronger in the younger twins (HR, 2.9; P0.0036 versus HR,
1.65; P0.0514), although the difference is not statistically
significant. We had expected that AF in the younger twins
would be more genetic, because they do not have the same
degree of concomitant diseases that increases the risk of AF.
Age and sex are known to be strongly associated with risk of
AF with male sex and increasing age as predictors of
increasing risk, but in our model only age and zygosity was
significantly associated with risk for AF. Furthermore, the
increase in risk associated to zygosity was higher than that
associated with a 10-year increase in age. Testing the distri-
bution of events stratified for sex and zygosity in the age
groups younger than 65 years showed an odds ratio for AF of
5.2 for women and 2.7 for men (Table 3), suggesting a
stronger association between zygosity and AF for women
than for men in the younger age groups, although the
difference between the 2 groups were nonsignificant. This
finding is in accordance with data from the Framingham
Heart Study,12 in which female AF had a stronger association
with risk of AF in offspring than in male AF. In the present
analysis, this trend increased with decreasing age, and we
speculate whether the explanation may be that female AF in
the younger age groups is more likely to be “lone AF” and
therefore more genetic in nature. This would imply that AF
in the older age groups to a higher degree is associated with
concomitant conditions such as hypertension, ischemic heart
disease, diabetes, and obesity—all conditions with a male
predominance. Disorders with a genetic predisposition often
Table 4. Contingency Tables and Prevalence of AF Among
Danish Twins Subdivided Into Sex and Zygosity Groups
MZ
Twin 2
DZ
Twin 2
Twin 1 AF AF AF AF
Women AF 19 63 21 164
AF 63 5.001 164 7.916
Prevalence
(95% CI), %
1.58 (1.35–1.84) 2.24 (2.02–2.48)
Men AF 25 93 27 203
AF 93 4.821 203 8.542
Prevalence
(95% CI), %
2.35 (2.07–2.67) 2.56 (2.33–2.80)
Both sexes AF 44 156 48 367
AF 156 9.822 367 16.458
Prevalence
(95% CI), %
1.97 (1.78–2.17) 2.41 (2.25–2.57)
Table 3. Distribution of Events Stratified for Sex and Zygosity
and With Age at Diagnosis of Index Twin <65 Years (n391)
Women Men
MZ DZ MZ DZ
No event 15 (79%) 78 (95%) 67 (85%) 155 (94%)
AF 4 (21%) 4 (5%) 12 (15%) 10 (6%)
Total 19 (100%) 82 (100%) 79 (100%) 165 (100%)
Odds ratio (95% CI) 5.2 (1.2–23.1) 2.7 (1.1–6.7)
Distribution of events differed significantly between MZ and DZ twins for
both sexes; 2 and Fisher exact test (P0.034 for women; P0.020 for men).
Table 5. Tetrachoric Correlations
rMZ (95% CI) rDZ (95% CI) P Value*
Women 0.66 (0.54–0.75) 0.36 (0.25–0.46) 0.01
Men 0.56 (0.45–0.65) 0.35 (0.25–0.45) 0.08
rMZ indicates correlation coefficient for MZ twins; rDZ, correlation coefficient
for DZ twins.
*Test for equal threshold for MZ and DZ.
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occur at a younger age. As mentioned, AF primarily is a
disease of the elderly, but occasionally patients as young as in
their early 20s are seen. The younger the patients are, the
more likely they will present with AF in the absence of major
predisposing conditions and therefore presumably with AF of
a more genetic nature. Although we see a trend toward this
conclusion in claiming that young female participants in our
study present the strongest association between zygosity and
AF, the present data suggest that AF in all age groups has a
considerable genetic component.
This study provides estimates of the sources of the vari-
ability in AF occurrence. Currently, a number of loci that
confer increased vulnerability to AF and variance in candi-
date genes have been found both through linkage studies and
genome-wide association studies. Association between loci on
chromosome 1025 and 626 have been reported, and the list of
candidate genes is currently expanding: KCNQ1,9 KCNJ2,10
KCNE5,14 KCNE2,11 and the genes behind the renin-angioten-
sin system15 and PITX2.16 The heritability estimates give a very
helpful overall estimate of the influence of genetic factors and
can give us information about the prospect of identifying further
genetic variants of importance for AF.
Conclusion
Monozygosity associates with increased risk of AF for twins
whose twin-sibling has been diagnosed with AF. Assuming
that the major difference between MZ and DZ twins is the
degree of genetic similarity, we interpret this difference in
risk of AF to be caused by genetic factors, and biometric
models suggest a degree of heritability in AF as high as 62%.
Study Limitations
The quality of the diagnoses in The Danish National Patient
Registry is a topic for discussion. In a former validation of the
registry, review of 116 medical records by a cardiologist
confirmed the diagnoses in 112 cases.27 Twins diagnosed
with AF before 1977 and not on any later occasion will not be
registered in The Danish National Patient Registry. This
potential misclassification was minimized by only including
twins older than 65 years at the time of start of the registry.
Misclassification regarding the diagnosis is most likely
independent of zygosity and will make the concordance rates
smaller in both groups of twins, thus making the groups more
similar and increasing the probability of the null hypothesis.
Despite this fact, we have found a strong heritability estimate.
We make the assumption that any differences in concor-
dance rates between MZ and DZ twins is due to the difference
in their degree of genetic relatedness. This is standard twin
methodology, and all twin heritability estimates are made
under the “equal environment assumption,” that is, the degree
of intrapair similarity due to the common environment is
equal in monozygotic and dizygotic twins. This assumption
has been much debated and investigated, and it has generally
been shown to be a valid and robust assumption.28
The majority of excluded twins were excluded because of
lack of follow-up information about the co-twin. This was
most frequent among the older twin pairs, thus reflecting
differences in data handling and collection over time and not
differential reporting depending on zygosity or disease status.
Regarding the group of twins born before 1912, 27 twin pairs
that otherwise qualified for inclusion were excluded: 17 DZ
(same sex) and 10 MZ pairs. None of these pairs were
concordant with respect to disease. From the population in the
analysis, the expected distribution of zygosity and concor-
dance in a group of 27 twin pairs would be 19 DZ (same sex)
and 8 MZ pairs, and of these, 2 pairs would be concordant. It
is therefore not likely that any significant bias is introduced
by this exclusion.
General practitioners in Denmark do not register ICD
diagnoses in the NPR. Therefore, affected twins who have not
been hospitalized but only diagnosed by their general practi-
tioner will not be included in this study. This means that the
actual number of both MZ and DZ twins with AF may be
higher. Certain clinical conditions, such as hypertension,
ischemic heart disease, diabetes, and hyperthyroidism, are
strong risk factors for AF. Our study design unfortunately did
not give us the opportunity to assess the distribution of these
risk factors among our twin population. Because these con-
ditions also are suspected to be at least to some degree
heritable, this may be a potential bias.
Monozygotic twins know that they share most of their
phenotypic traits because they are “identical twins,” as
opposed to dizygotic twins, who may not resemble each other
Table 6. Model-Fit Statistics for Biometric Models
Women Men
Model AIC vs df 2 P Value AIC vs df 2 P Value
ACE 6.08 2.53
ADE 6.34 5.70
AE 4.34 ACE 1 0.26 0.61 3.45 ACE 1 1.08 0.30
CE 17.3 ACE 1 13.3 0.001 4.24 ACE 1 8.77 0.01
DE 15.3 ADE 1 10.9 0.01 29.1 ADE 1 25.4 0.001
E 117 AE 1 115 0.001 109 AE 1 115 0.001
A indicates additive genetic effects; D, dominant genetic effects; E, shared environmental effects; C, nonshared
environmental effects; AIC, Akaike Information Criterion; df, difference in degrees of freedom; 2, difference in 2.
Table 7. Variance Components for AE Models
Both Sexes Women Men
a2 (95% CI) 0.62 (0.55–0.68) 0.67 (0.57–0.76) 0.59 (0.49–0.67)
e2 (95%CI) 0.38 (0.32–0.45) 0.33 (0.24–0.43) 0.41 (0.33–0.51)
a2 indicates additive genetic effects; e2, nonshared environmental effects.
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either physically or psychologically. A monozygotic twin
with a twin-sibling diagnosed with AF may therefore be more
eligible to seek a physician to be examined for this same
disease than a dizygotic twin with a co-twin diagnosed with
AF. This will overestimate monozygotic concordance rates.
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CLINICAL PERSPECTIVE
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. Familial clustering of AF has been known for
more than 70 years. In population studies, children of parents with AF have a nearly double or even greater risk of AF.
Mutations and polymorphisms in genes coding for ion channels involved in cardiac repolarization and connexins may be
involved in promoting AF. The present twin study confirms the basic notion that inherited factors play a role in the
development of AF and suggests that the importance of heritable factors may be greater than previously suggested. We find
that monozygotic twins have twice the concordance rate for AF as dizygotic twins. A monozygotic twin has twice the risk
of AF if his or her co-twin is diagnosed with AF, as compared with a dizygotic twin in the same situation. We estimate
the heritability of AF to be as high as 67%. Family history is an important factor to take into consideration in the evaluation
of patients at risk for development of AF. Understanding the genetic components and how they contribute to the pathophysiology
leading to AF may lead to new approaches in diagnosis, prevention, and treatment of this common cardiac arrhythmia.
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